{"nct_id":"NCT02005315","title":"A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2013-09","start_date_type":"ACTUAL","primary_completion_date":"2017-10","primary_completion_date_type":"ACTUAL","completion_date":"2017-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MREO"]}